Novo Nordisk to test next-gen obesity drug CagriSema in children
- Posted on December 2, 2025
- By AOL
- 1 Views
Novo Nordisk to test next-gen obesity drug CagriSema in children
Dec 2 () - Wegovy maker Novo Nordisk is planning to test its experimental obesity drug, CagriSema, in overweight children and adolescents, according to a U. The late-stage trial, set to begin in January, is expected to enroll 460 children as young as eight years across 97 test centers globally, including the U.
